Objective: The goal of this article was to investigate the diagnosis, treatment and mechanisms of the leukemoid reaction (LKR) associated with transitional cell carcinoma. Methods: A 64-year-old male patient presented with anuria. Color ultrasound imaging revealed a large bladder tumor. Digital radiography and computerized tomography of the chest, abdomen and pelvis revealed only bilateral hydronephrosis, but did not reveal any metastasis. The preoperative white blood cell count in the peripheral blood consistently increased to 58,400/mm 3 while neutrophil granulocyte count was 54,900/mm 3 , without fever. Radical cystectomy and construction of bilateral cutaneous ureterostomy was performed. The histological diagnosis was transitional cell carcinoma, grade 3. Granulocyte colonystimulating factor (G-CSF) staining was positive in tumor cells. Results: After surgery, the leukocyte value became nearly normal. At 3 months later, patient was admitted to our hospital with the complaints of the left leg edema, diagnosed as pelvic lymph node metastasis. Patient died of systemic metastasis within 6 months after the cystectomy. Conclusions: Bladder cancer associated with LKR, though rare, is considered highly malignant, difficult to diagnose and as having poor prognosis.
AB136. Herpes zoster associated with acute urinary retention: 2 case reports and literature review
Haowei He
Nanjing General Hospital, Nanjing 210002, China Objective: A 67-year-old woman with a 6-day history of urinary retention incontinence during which she had been herpes zoster virus (HZV). Methods: On physical exam painful vesicles involving the right vulvar and buttock were found; a 42-year-old man with a one week history of urinary retention. Results: He presented with painful vesicular eruptions on his left buttock for about 11-day. The diagnosis is herpes zoster associated with acute urinary retention. Conclusions: The patients were given antiviral, antiinflammatory therapies, when the catheters were removed, and the patients were able to pass urine as normal. Methods: In the present study, using specific anit-EphB1 polyclonal antibody and immunohistochemistry, we evaluated EphB1 protein expression levels in renal cell carcinoma (RCC) specimens surgically resected from 82 patients (including 62 conventional clear-cell RCC, 10 papillary, and 10 chromophobic RCC cases). Results: We found EphB1 protein is positively expressed in the epithelium of renal tubules. Decreased expression of EphB1 was found in all RCC carcinomas compared with expression in the normal epithelium of renal tubules. EphB1 protein moderately expressed in chromophobic RCC, weakly expressed in clear-cell RCC and negatively expressed in papillary RCC.
Conclusions:
Our results indicate that EphB1 may be involved in carcinogenesis of RCC, the molecular mechanisms of down-regulation of EphB1 including genetic and epigenetic alterations and the dedicated roles of EphB1 in occurrence and progress of RCC need to be explicated in next step. Objective: To study the safety and efficacy of thulium laser treatment of bladder cancer. Methods: Thulium laser surgery system was used for the treatment of 45 cases of bladder cancer patients, including 33 cases of single tumor, 12 cases of multiple tumors. Tumor diameter were 5-25 mm. Tumor pathology were bladder transitional cell carcinoma, clinical stage at T1-T2. Results: All the surgery was successfully completion. Operation time was 10-35 minutes. Blood loss was 0-5 mL. None of bladder has perforation, water intoxication, urinary leakage or postoperative bleeding. All of the patients had received immediate intravesical chemotherapy within 0.5 hours, and to maintain bladder chemotherapy. All had catheter indwelled 5 to 7 days. Patients were followed up 1 year, no recurrence of the surgical area. Conclusions: Thulium laser surgery system for the transurethral treatment of bladder cancer within stage T2 is safe and effective. Objective: To investigate whether low-dose BCG treatment can reduce the side effects while maintaining efficacy for patients with NMIBC when compared with standard dose BCG treatment. Methods: A comprehensive literature search of PubMed, EMBASE, CINAHL, LILACS and CENTRAL databases was conducted to identify relevant randomized controlled trials (RCT) or quasi-randomized controlled trials (qRCT) that have assessed the efficacy of low and standard dose BCG therapy for patients with NMIBC. Systematic review and meta-analysis were performed according to preferred reporting items for systematic reviews and meta-analysis criteria. Results: Six RCTs and two qRCTs were eligible for metaanalysis. Low-dose BCG instillation was not inferior to reduce the risk of bladder tumor recurrence [hazard ratio (HR), 1.15; 95% confidence interval (CI), 1.00-1.31; P=0.05], meanwhile no difference was found regarding tumor progression (HR =1.08; 95% CI, 0.83-1.42; P=0.57). However, low-dose BCG provided a significantly lower incidence of overall side effects (RR =0.75; 95% CI,
